Cystic fibrosis is a genetic disease due to a malfunction of the CFTR chlorine channel that leads to severe reliance of respiratory infections, malabsorption and other complications affecting many organs and systems. The therapies are aimed at restoring CFTR whenever possible, improving nutritional status and preventing or treating respiratory infections.
The aim of the research group is to identify markers of clinical progress and to implement complementary therapies to those currently available for cystic fibrosis patients.
date/time interval:
(November 1, 2015 - )